Handelsinvest Investeringsforvaltning Sells 411 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Handelsinvest Investeringsforvaltning reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 8.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,749 shares of the healthcare conglomerate’s stock after selling 411 shares during the quarter. UnitedHealth Group comprises 1.1% of Handelsinvest Investeringsforvaltning’s holdings, making the stock its 12th biggest position. Handelsinvest Investeringsforvaltning’s holdings in UnitedHealth Group were worth $2,349,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $26,000. CGC Financial Services LLC grew its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $31,000. LFA Lugano Financial Advisors SA grew its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. Finally, Transcendent Capital Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $40,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on UNH. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 12th. Finally, Robert W. Baird assumed coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $579.74.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $498.00 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $458.35 billion, a PE ratio of 30.45, a P/E/G ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a 50-day moving average price of $498.40 and a two-hundred day moving average price of $501.35.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the company earned $6.26 earnings per share. The firm’s revenue was up 8.6% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s payout ratio is presently 51.34%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.